ifosfamide and serine

ifosfamide has been researched along with serine in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Babovic, N; Blay, JY; Bompas, E; Chawla, SP; Cohen, P; Cupissol, D; Demetri, GD; Franke, FA; Isambert, N; Italiano, A; Le-Guennec, S; López-Pousa, A; Pápai, Z; Penel, N; Saâda-Bouzid, E; Santoro, A; Staddon, AP; Tolcher, AW	1

Trials

1 trial(s) available for ifosfamide and serine

Article	Year
Ombrabulin plus cisplatin versus placebo plus cisplatin in patients with advanced soft-tissue sarcomas after failure of anthracycline and ifosfamide chemotherapy: a randomised, double-blind, placebo-controlled, phase 3 trial. The Lancet. Oncology, 2015, Volume: 16, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Anthracyclines; Cisplatin; Disease-Free Survival; Double-Blind Method; Drug Administration Schedule; Female; Humans; Ifosfamide; Male; Middle Aged; Proportional Hazards Models; Sarcoma; Serine; Treatment Outcome	2015

Article

Year

Ombrabulin plus cisplatin versus placebo plus cisplatin in patients with advanced soft-tissue sarcomas after failure of anthracycline and ifosfamide chemotherapy: a randomised, double-blind, placebo-controlled, phase 3 trial.

The Lancet. Oncology, 2015, Volume: 16, Issue:5

Topics: Adult; Aged; Aged, 80 and over; Anthracyclines; Cisplatin; Disease-Free Survival; Double-Blind Method; Drug Administration Schedule; Female; Humans; Ifosfamide; Male; Middle Aged; Proportional Hazards Models; Sarcoma; Serine; Treatment Outcome

2015